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THE VALUE OF THE PAPANICOLAOU SMEAR TEST*
ZEPH J. R. HOLLENBECK, M.D.**

Clinical experience and research in therapy of cancer of the female genitalia
and especially of the cervix have given us much with which to work. We have
radio-isotopes: super-voltage x-ray: teletherapy; radical surgery, and above all, we
have a tremendous store of knowledge in methods of application of all of these. And
yel, when we consider all cases of the most common cancer of the female senitalia —
cancer of the cervix — more than 60% of them do not live 5 years (after the diagnosis
is made.)
When we look at the results of treatment year after year and decade after
decade, we are not startled by the improvement in these results because they have
been slow to make their appearances; but one thing is very much in evidence. It
is the fact that as in all types of cancer, the earlie^ in the disease that therapy is
begun, the better are the results.
In addition to public education, which has improved this feature of the whole
picture, we need a method to detect cancer early. In other words, we need a "case
finder". We have it! We have it! At least, we have one method — the Papanicolaou
smear test. We have it, and we have had this tool for some time — but it has nor
been widely used. It will do little good to print it here unless those who read this
put it into practice. William Stewart Halstead once said, "conceptions from the past
bUnd us to facts which almost slap us in the face."
It is our belief that every woman should have a pelvic examination and a vaginal
cytology study at least once every year. I will outline briefly the results of a survey
which has led us to an even stronger conviction in this belief.
A country-wide cancer survey project using the Papanicolaou smear as a screen
test has been in operation in Columbus, Ohio for the past year. This has been done
under the co-directorship of Dr. John C. Ullery, Chairman of the Department of
Obstetrics and Gynecology and Dr. Emmerich Von Haan, Chairman of the Department
of Pathology of the Ohio State University, and with the aid of a grant from the
United States Public Health Service.
A similiar survey has been in progress in Memphis, Tennessee for the past three
years. The Memphis survey study has found 527 carcinomas in 70,000 examinations
or an incidence of 0.75% (1 in 143). In the Columbus survey, we have found 99
carcinomas in 35,394 examinations or an incidence of 0.279% (1 in 357.)
The source of the material for examinations has come from private physicians
(27,669), The Cancer Survey Clinic (3,169) and from other clinics (6,675).
The method of making the test is simple and painless. The material from the
posterior vaginal fornix is removed with an aspirator and placed on a glass slide.
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This is covered with another slide, and the two are slid apart. The second specimen
is prepared after the vaginal speculum is in place by scraping the area around and
in the external OS of the cervix with a tongue depressor or a wooden scraper designed
for this purpose. The material obtained is placed on the slide, and the slides are
fixed and transported to the laboratory in a mixture of equal parts 95% alcohol
and ether.
In the Columbus study the "aspiration only" method is being used with a
control run by a designated few physicians who are using both the aspiration and
scrape. 37,540 aspirations and approximately 5,260 aspirations and scrapes have been
surveyed. Eleven (11) patients with cancer were found on positive scrape smears
that were negative on aspiration.
In applying this test in your own practice, your cytologist may report his findings
in one of three ways; by class, by cytology or by interpretation.
CLASSIFICATION OF PAPANICOLAOU SMEARS
CLASS
I

CYTOLOGY

INTERPRETATION

Normal

Negative

II

Atypical, No
Evidence Malignancy

Negative

III

Suspicious, Suggestive —
Not Conclusive

IV

Strongly Suggestive

Positive

V

Conclusive of
Malignancy

Positive

Suspicious
(Positive)

The suspicious or positive smear demands an adequate biopsy of the cervix,
preferably by cold knife conization, a D&C and an adequate pelvic examination under
anaesthesia. It must be emphasized here that this test is not infallible, and a negative
report in the face of symptoms or positive, clinical findings means absolutely nothing.
A patient presenting a suggestive history or suspicious or presumptive findings must
have adequate biopsy and examination. This sequence of events, symptoms with
negative smear, usually occurs in endometrial cancer.
We must also remember that a positive smear is by no means an indication for
therapy. Definitive cancer treatment must be initiated only as a result of a positive
biopsy.
In one year, from May 1, 1956 to May 1, 1957, there were 99 cancers of the
female genital tract found in our survey of 35,394 women; the various types of
carcinomas are as follows;
M A Y 1, 1956 — M A Y 1, 1957
Carcinoma of the Cervix
(Three — Cervical Stump)
Carcinoma of the Corpus
Carcinoma in Situ — Cervix
(One during Pregnancy)
Carcinoma of the Vagina
Carcinoma of the Ovary
TOTAL

240

52
12
31
3
1
99

Papanicolaou Smear Test
Most of these tumors were unsuspected, but to appreciate the full and tremendous
value of the routine Papanicolaou test in detecting 83 cancers of the cervix (of a
total of 99 carcinomas), it is well to remember again the International Clinical Classirication of Cancer of the Cervix. Stage 0, Microscopically No Invasion (intra-epithelial); Stage I , Limited Clinically to the Cervix; Stage I I , Extending Beyond the Cervix
but not to the Lateral Pelvic Wall (may also involve the upper 1/3 of the vagina);
Stage I I I , Extending Laterally to the Pelvic Wall (or extending below the upper 1/3
of the vagina); Stage IV, With Distant Metastasis (or a frozen pelvis or bowel or
bladder fistulization due to tumor).
The 83 cervical cancers were classified clinically as follows:
Stage 0

31

Stage I

40

Stage I I
Stage I I I
Stage IV
TOTAL

83

To further appreciate the value of the Papanicolaou smear we must look at our
present results of therapy. These statistics from the Department of Obstetrics and
Gynecology of the Ohio State University compare favorably with nationwide and
world wide publications of survival rates.
FIVE YEAR SURVIVAL
Stage 0

96.2%

Stage I

' 81.4%

Stage I I

48.5%

Stage I I I

21.4%

Stage I V

2.5%

With these survivals of the various clinical stages of cervical cancer in mind,
let us now compare the difference between the registrations in the tumor clinic at
the Ohio State University Hospital ten years ago with the cases found by means of a
mass survey during the year just past.
1947

Stage

1957

0%

0

38%

14%

I

48%

41%

II

5%

41%

III

7%

4%

IV

2%

This is truly progress.
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Cancer of the cervix has three clinical characteristics that are extremely important
in appreciating the value of the Papanicolaou smear test. First, it is, by far, the most
common cancer of the female genital tract. Second, relatively good results are obtained
if adequate treatment is instituted early. Third, it is the easiest to detect early of all
the cancers of the female genitalia.
This test can be applied to anyone's practice who treats women. One way to
reduce the 60% mortality rate from cancer of the cervix is to use this simple test
routinely.
It seems then that your mother, your wife, your daughter, your sister, yes —
every woman deserves and should have a pelvic examination and a "Cancer Smear Test"
at least once a year.

Forty South Third Street
Columbus 15, Ohio
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